AEPCX
Price
$51.92
Change
-$1.50 (-2.81%)
Updated
Apr 3 closing price
Net Assets
125.35B
QIORX
Price
$15.04
Change
-$0.36 (-2.34%)
Updated
Apr 3 closing price
Net Assets
172.92M
Ad is loading...

AEPCX vs QIORX

Header iconAEPCX vs QIORX Comparison
Open Charts AEPCX vs QIORXBanner chart's image
American Funds Europacific Growth C
Price$51.92
Change-$1.50 (-2.81%)
VolumeN/A
Net Assets125.35B
AQR International Momentum Style R6
Price$15.04
Change-$0.36 (-2.34%)
VolumeN/A
Net Assets172.92M
AEPCX vs QIORX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. QIORX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and QIORX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 125B vs. QIORX (173M). QIORX pays higher dividends than AEPCX: QIORX (3.23) vs AEPCX (0.35). AEPCX was incepted earlier than QIORX: AEPCX (24 years) vs QIORX (11 years). AEPCX (1.59) is less costly to investors than QIORX (0.63). QIORX is a more actively managed with annual turnover of: 56.00 vs. AEPCX (30.00). AEPCX has a lower initial minimum investment than QIORX: AEPCX (250) vs QIORX (50000000). AEPCX annual gain was more profitable for investors over the last year : -7.70 vs. QIORX (-8.56). QIORX return over 5 years is better than : 48.19 vs. AEPCX (32.00).
AEPCXQIORXAEPCX / QIORX
Total Expense Ratio1.590.53300%
Annual Report Gross Expense Ratio1.590.63252%
Fund Existence24 years11 years-
Gain YTD0.4849.7655%
Front LoadN/AN/A-
Min. Initial Investment250500000000%
Min. Initial Investment IRAN/AN/A-
Net Assets125B173M72,254%
Annual Yield % from dividends0.353.2311%
Returns for 1 year-7.70-8.5690%
Returns for 3 years-6.24-4.18149%
Returns for 5 years32.0048.1966%
Returns for 10 years6.5437.3917%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DBVT7.860.16
+2.08%
DBV Technologies S.A
NLSP1.49N/A
N/A
Nls Pharmaceutics Ltd
CRL140.98-8.30
-5.56%
Charles River Laboratories International
USAC25.84-1.85
-6.68%
USA Compression Partners LP
TTGT9.37-3.13
-25.04%
TechTarget